No record in the supplied claim-level evidence involves Apis mellifera, gut commensals such as Snodgrassella, Gilliamella, or Lactobacillus Firm-4/Firm-5, absolute quantification, or 16S copy-number per-genome corrections. Because citations may only be drawn from the conversation, the query's premise cannot be answered with honey beeβspecific data β I decline the premise rather than fabricate bee values.
The records do bear on one central caveat of absolute 16S quantification: PCR-amplified 16S data are contaminated by artifacts. Mallard screening of 25 public libraries (222β270 sequences each) found ~9% anomalies on average, up to 45.8%, with 493 confirmed chimeras among 714 putative anomalies . Chimeras inflate copy-number-normalized taxon abundance and thus corrupt absolute cell-count estimates.
Two further sourced caveats: 16S rRNA copies (DNA) do not distinguish active from dormant cells β RNA:DNA comparisons in sponges showed divergent activity profiles, so amplicon counts are a poor proxy for viable cell numbers ; and whole-genome shotgun detects more species and diversity than 16S amplicons in a direct head-to-head of one fecal sample (194.1M reads) . Copy-number variation itself (multi-copy rrn operons differing by taxon) is a known, unresolved bias for converting 16S copies to cells β none of the supplied records quantifies it for bee gut taxa, so I make no claim about its magnitude.
Missing evidence to battle-test the original claim: bee-gut qPCR primer specificity data, per-taxon rrn copy numbers from closed bee-gut genomes, spike-in standard recovery curves, and matched WGS absolute counts. What would disprove the caveat framing: a bee-gut validation showing 16S copy-normalized qPCR agrees with flow cytometry or spike-in standards within stated error.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.